Timing and characteristics of radiation pneumonitis after stereotactic body radiotherapy for peripherally located stage I lung cancer

International Journal of Clinical Oncology

Volumn 20, Issue 4, 2015, Pages 680-685

  Kanemoto, Ayae ^a   Matsumoto, Yasuo ^a   Sugita, Tadashi ^a  

^a NIIGATA CANCER CENTER HOSPITAL   (Japan)

Author keywords

Predictive factor; Radiation pneumonitis; Stage I lung cancer; Stereotactic body radiotherapy; Timing

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER STAGING; CONTROLLED STUDY; FEMALE; HUMAN; INCIDENCE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION PNEUMONIA; STEREOTACTIC BODY RADIATION THERAPY; ADVERSE EFFECTS; CARCINOMA, NON-SMALL-CELL LUNG; LUNG NEOPLASMS; MIDDLE AGED; RADIATION PNEUMONITIS; RADIOSURGERY; RETROSPECTIVE STUDY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; RADIATION PNEUMONITIS; RADIOSURGERY; RETROSPECTIVE STUDIES;

EID: 84938745774     PISSN: 13419625     EISSN: 14377772     Source Type: Journal    
DOI: 10.1007/s10147-014-0766-3     Document Type: Article

References (14)

1. Onishi H, Araki T (2013) Stereotactic body radiation therapy for stage I non-small-cell lung cancer: a historical overview of clinical studies. Jpn J Clin Oncol 43:345–350
2. Chi A, Liao Z, Nguyen NP et al (2010) Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: clinical implications. Radiother Oncol 94:1–11
3. Simone CB 2nd, Wildt B, Haas AR et al (2013) Stereotactic body radiation therapy for lung cancer. Chest 143:1784–1790
4. Linda A, Trovo M, Bradley JD (2011) Radiation injury of the lung after stereotactic body radiation therapy (SBRT) for lung cancer: a timeline and pattern of CT changes. Eur J Radiol 79:147–154
5. Baker R, Han G, Sarangkasiri S et al (2013) Clinical and dosimetric predictors of radiation pneumonitis in a large series of patients treated with stereotactic body radiation therapy to the lung. Int J Radiat Oncol Biol Phys 85:190–195
6. Barriger RB, Forquer JA, Brabham JG et al (2012) A dose-volume analysis of radiation pneumonitis in non-small cell lung cancer patients treated with stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 82:457–462
7. Liu H, Zhang X, Vinogradskiy YY et al (2012) Predicting radiation pneumonitis after stereotactic ablative radiation therapy in patients previously treated with conventional thoracic radiation therapy. Int J Radiat Oncol Biol Phys 84:1017–1023
8. Takeda A, Ohashi T, Kunieda E et al (2010) Early graphical appearance of radiation pneumonitis correlates with the severity of radiation pneumonitis after stereotactic body radiotherapy (SBRT) in patients with lung tumors. Int J Radiat Oncol Biol Phys 77:685–690
9. Trovo M, Linda A, El Naqa I et al (2010) Early and late lung radiographic injury following stereotactic body radiation therapy (SBRT). Lung Cancer 69:77–85
10. Guckenberger M, Baier K, Polat B et al (2010) Dose-response relationship for radiation-induced pneumonitis after pulmonary stereotactic body radiotherapy. Radiother Oncol 97:65–70
11. Matsuo Y, Shibuya K, Nakamura M et al (2012) Dose–volume metrics associated with radiation pneumonitis after stereotactic body radiation therapy for lung cancer. Int J Radiat Oncol Biol Phys 83:e545–e549
12. Bongers EM, Botticella A, Palma DA et al (2013) Predictive parameters of symptomatic radiation pneumonitis following stereotactic or hypofractionated radiotherapy delivered using volumetric modulated arcs. Radiother Oncol 109:95–99
13. Yamashita H, Kobayashi-Shibata S, Terahara A et al (2010) Prescreening based on the presence of CT-scan abnormalities and biomarkers (KL-6 and SP-D) may reduce severe radiation pneumonitis after stereotactic radiotherapy. Radiat Oncol 5:32
14. Chang JY, Liu H, Balter P et al (2012) Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer. Radiat Oncol 7:152